Efthymia Papaevangelou
Overview
Explore the profile of Efthymia Papaevangelou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
169
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Papaevangelou E, Esteves A, Dasgupta P, Galustian C
Front Immunol
. 2023 Jul;
14:1196829.
PMID: 37465665
Introduction: Prostate cancer is one of the most commonly diagnosed malignancies in men with high mortality rates. Despite the recent therapeutic advances, such as immunotherapies, survival of patients with advance...
2.
Owczarek C, Ortiz-Zapater E, Kim J, Papaevangelou E, Santis G, Parsons M
Front Oncol
. 2022 Mar;
12:829313.
PMID: 35252000
The coxsackie and adenovirus receptor (CAR) is a member of the junctional adhesion molecule (JAM) family of adhesion receptors and is localised to epithelial cell tight and adherens junctions. CAR...
3.
Esteves A, Papaevangelou E, Smolarek D, Dasgupta P, Galustian C
Front Mol Biosci
. 2021 Nov;
8:755764.
PMID: 34778376
Interleukin-15 (IL-15) is a cytokine previously suggested as a potential immunotherapy for cancer treatment. IL-15 can effectively reduce tumor growth in many preclinical tumor models including prostate cancer. This is...
4.
Esteves A, Papaevangelou E, Dasgupta P, Galustian C
Front Oncol
. 2021 Mar;
11:621550.
PMID: 33777767
Prostate cancer is the second most commonly diagnosed cancer in men with mortality rates, overtaking those for breast cancer in the last 2 years in the UK. Despite advances in...
5.
Watkinson F, Nayar S, Rani A, Sakellariou C, Elhage O, Papaevangelou E, et al.
Front Immunol
. 2021 Feb;
11:594620.
PMID: 33537030
Interleukin-15 (IL-15) is a cytokine that has been shown to expand CD8 T cell and natural killer (NK) cell populations, and therefore has potential for potentiating adoptive immune cell therapy...
6.
Papaevangelou E, Smolarek D, Smith R, Dasgupta P, Galustian C
Immunotargets Ther
. 2020 Aug;
9:115-130.
PMID: 32802803
Background: The prostate cancer microenvironment is highly immunosuppressive; immune cells stimulated in the periphery by systemic immunotherapies will be rendered inactive once entering this environment. Immunotherapies for prostate cancer need...
7.
Sakellariou C, Elhage O, Papaevangelou E, Giustarini G, Esteves A, Smolarek D, et al.
BJU Int
. 2019 Aug;
125(1):89-102.
PMID: 31392791
Objectives: To identify cytokines that can activate and expand NK cells in the presence of prostate cancer cells in order to determine whether these agents may be useful in future...
8.
Martinho Costa M, Shah A, Rivens I, Box C, OShea T, Papaevangelou E, et al.
Photoacoustics
. 2018 Dec;
13:53-65.
PMID: 30581729
Photoacoustic imaging (PAI) provides information on haemoglobin levels and blood oxygenation (sO). To facilitate assessment of the variability in sO and haemoglobin in tumours, for example in response to therapies,...
9.
Papaevangelou E, Boult J, Whitley G, Robinson S, Howe F
Angiogenesis
. 2018 May;
21(4):737-749.
PMID: 29721731
Nitric oxide (NO) has been strongly implicated in glioma progression and angiogenesis. The endogenous inhibitors of NO synthesis, asymmetric dimethylarginine (ADMA) and N-monomethyl-L-arginine (L-NMMA), are metabolized by dimethylarginine dimethylaminohydrolase (DDAH),...
10.
Papaevangelou E, Almeida G, Box C, deSouza N, Chung Y
Int J Cancer
. 2018 Mar;
143(4):992-1002.
PMID: 29569717
Overexpression of fatty acid synthase (FASN), a key regulator of the de novo synthesis of fatty acids, has been demonstrated in a variety of cancers and is associated with poor...